Search or
𝛼SK
𝛼SKbullish
EOFlow (Further) Tests Investor Patience
1.6k Views24 Nov 2023 09:06
Medtronic needs to step up here, ahead of the next collateralised expiry date. EOFlow has overshot to the downside. Down 38% since the resumption of trading. If not in, I'd be picking up shares here.
Boomeranged on Tue, 5 Dec 2023 16:02
The Appellant Brief Is out. EOFlow flags. inter alia, the statute of limitations; whether Insulet faces a significant risk of irreparable harm; that the court misapplied trade secret law and failed to meaningfully weigh the balance of harms to the public interest; Insulet failed to identify trade secrets (or protect asserted trade secrets), and the differences between Insulet & EOFlow’s products.
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- EOFlow (294090 KS): Suitably Pumped23 May 2024
- EOFlow Craters. Medtronic Stays Mum16 Nov 2023
- Eoflow: Outlook After Trading Resumes on 16 November16 Nov 2023
x